Metlife (MET) Stock Forecast & Price Target
MET Analyst Ratings
Strong Buy
11Buy1Hold0Sell
Based on 12 analysts giving stock ratings to Metlife in the past 3 months
MET Stock 12 Month Forecast
Average Price Target
MXN 2,106.22▲(12.03% Upside)Based on 12 Wall Street analysts offering 12 month price targets for Metlife in the last 3 months. The average price target is MXN 2,106.22 with a high forecast of MXN 2,246.98 and a low forecast of MXN 2,039.27. The average price target represents a 12.03% change from the last price of MXN 1,880.00.
Past 12 Months12 Month ForecastDec2025Sep2026
HighMXN 2.25K
AverageMXN 2.11K
LowMXN 2.04K
Highest Price TargetHighestMXN 2,246.98Average Price TargetMXN 2,106.22Lowest Price TargetLowestMXN 2,039.27
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Andrew Kligerman | TD Cowen | MXN 2,077.04→MXN 2,152.57 | buy | 14.50%Upside | Reiterated | 10/21/26 | ||
| Pablo Singzon | J.P. Morgan | MXN 2,039.27→MXN 2,077.04 | buy | 10.48%Upside | Assigned | 10/15/26 | ||
| Joshua Shanker | Bank of America Securities | MXN 2,246.98 | buy | 19.52%Upside | Reiterated | 10/12/26 | ||
| Paul Newsome | Piper Sandler | MXN 2,077.04 | buy | 10.48%Upside | Reiterated | 10/12/26 | ||
| Wesley Carmichael | Wells Fargo | MXN 2,058.16→MXN 2,077.04 | buy | 10.48%Upside | Reiterated | 10/12/26 | ||
| Ryan Krueger | KBW | MXN 2,039.27 | buy | 8.47%Upside | Reiterated | 10/08/26 | ||
| Alex Scott | Barclays | MXN 1,831.57→MXN 2,095.92 | buy | 11.49%Upside | Reiterated | 10/07/26 | ||
| Yaron Kinar | Mizuho Securities | MXN 2,114.80→MXN 2,058.16 | buy | 9.48%Upside | Reiterated | 10/07/26 | ||
| Michael Ward CFA | UBS | MXN 1,982.63→MXN 2,077.04 | buy | 10.48%Upside | Reiterated | 10/06/26 | ||
| Bob Huang | Morgan Stanley | MXN 2,095.92 | buy | 11.49%Upside | Assigned | 10/05/26 | ||
| Suneet Kamath | Jefferies | MXN 1,944.86→MXN 2,171.45 | buy | 15.50%Upside | Reiterated | 10/01/26 | ||
| Wilma Burdis | Raymond James | ― | hold | ― | Reiterated | 09/29/26 | ||
| Thomas Gallagher | Evercore ISI | MXN 1,793.81→MXN 1,812.69 | hold | -3.58%Downside | Reiterated | 04/09/26 | ||
| Kevin Heal | Argus Research | MXN 1,699.40 | buy | -9.61%Downside | Reiterated | 12/08/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Andrew Kligerman | 10/21/26 | MXN 2,077.04→MXN 2,152.57 | buy | 14.50%Upside | Reiterated | TD Cowen | ||
| Pablo Singzon | 10/15/26 | MXN 2,039.27→MXN 2,077.04 | buy | 10.48%Upside | Assigned | J.P. Morgan | ||
| Joshua Shanker | 10/12/26 | MXN 2,246.98 | buy | 19.52%Upside | Reiterated | Bank of America Securities | ||
| Paul Newsome | 10/12/26 | MXN 2,077.04 | buy | 10.48%Upside | Reiterated | Piper Sandler | ||
| Wesley Carmichael | 10/12/26 | MXN 2,058.16→MXN 2,077.04 | buy | 10.48%Upside | Reiterated | Wells Fargo | ||
| Ryan Krueger | 10/08/26 | MXN 2,039.27 | buy | 8.47%Upside | Reiterated | KBW | ||
| Alex Scott | 10/07/26 | MXN 1,831.57→MXN 2,095.92 | buy | 11.49%Upside | Reiterated | Barclays | ||
| Yaron Kinar | 10/07/26 | MXN 2,114.80→MXN 2,058.16 | buy | 9.48%Upside | Reiterated | Mizuho Securities | ||
| Michael Ward CFA | 10/06/26 | MXN 1,982.63→MXN 2,077.04 | buy | 10.48%Upside | Reiterated | UBS | ||
| Bob Huang | 10/05/26 | MXN 2,095.92 | buy | 11.49%Upside | Assigned | Morgan Stanley | ||
| Suneet Kamath | 10/01/26 | MXN 1,944.86→MXN 2,171.45 | buy | 15.50%Upside | Reiterated | Jefferies | ||
| Wilma Burdis | 09/29/26 | ― | hold | ― | Reiterated | Raymond James | ||
| Thomas Gallagher | 04/09/26 | MXN 1,793.81→MXN 1,812.69 | hold | -3.58%Downside | Reiterated | Evercore ISI | ||
| Kevin Heal | 12/08/25 | MXN 1,699.40 | buy | -9.61%Downside | Reiterated | Argus Research |
Stocks with the Highest Top Analyst Consensus in the Financial Sector
Best Analysts Covering Metlife
3 Months
Success Rate25/36 ratings generated profit
69%
Average Return
+7.21%
Copying Ryan Krueger's trades and holding each position for 3 Months would result in 69.44% of your transactions generating a profit, with an average return of +7.21% per trade.
1 Year
Success Rate32/36 ratings generated profit
89%
Average Return
+17.97%
Copying Ryan Krueger's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +17.97% per trade.
2 Years
Success Rate18/18 ratings generated profit
100%
Average Return
+28.19%
Copying Alex Scott's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +28.19% per trade.
MET Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 15 | 19 | 19 | 20 | 22 |
| Hold | 7 | 5 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 22 | 24 | 22 | 22 | 24 |
In the current month, MET has received 22 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. MET average Analyst price target in the past 3 months is 2,106.22.
MET Financial Forecast
HighMXN 54.67
ConsensusMXN 52.11
LowMXN 49.20
MET Earnings Forecast
Next quarter’s earnings estimate for MET is MXN 52.11 with a range of MXN 49.20 to MXN 54.67. The previous quarter’s EPS was MXN 45.65. Its overall industry beat the EPS estimate 81.82% of the time in the past 12 months.
HighMXN 380B
ConsensusMXN 373B
LowMXN 361B
MET Sales Forecast
Next quarter’s sales forecast for MET is MXN 373.00B with a range of MXN 360.75B to MXN 380.30B. The previous quarter’s sales results were MXN 362.78B. Its overall industry beat sales estimates 93.33% of the time in the past 12 months.
MET Stock Forecast FAQ
What is MX:MET’s average 12-month price target, according to analysts?
Based on analyst ratings, Metlife’s 12-month average price target is Mex$2,106.22.
What is MX:MET’s upside potential, based on the analysts’ average price target?
Metlife has 12.03% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Metlife a Buy, Sell or Hold?
Metlife has a consensus rating of Strong Buy, which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.
What is Metlife’s share price target?
The average share price target for Metlife is Mex$2,106.22. This is based on 12 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$2,246.98, and the lowest forecast is Mex$2,039.27. The average share price target represents a 12.03% increase from the current price of Mex$1,880.
What do analysts say about Metlife?
Metlife’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Street analysts.
How can I buy shares of Metlife?
To buy shares of MX:MET, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.